Pegylated Interferon Alfa-2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C
Clicks: 138
ID: 271150
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
138 views
26 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #556 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract. Background. Hemodialysis patients are at risk of hepatitis C virus (HCV) infection. However, little is known about the efficacy and safety of pegylate
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (24 words).
Try re-searching for a better abstract.
| Reference Key |
chen-hua2010clinicalpegylated
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Lin, Jou-Wei;Chen, Shih-I;Hung, Peir-Haur;Tsai, Hung-Bin;Lai, Ming-Yang;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; |
| Journal | clinical infectious diseases |
| Year | 2010 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.